Changes in Nucleolin Expression during Malignant Transformation Leading to Ovarian High-Grade Serous Carcinoma
Cancers · 21.01.2023 · 15 (3) · 661
DOI: 10.3390/cancers15030661 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 21.01.2023. Verfasst von Elizabeth A Paris und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy & Cell Biology, Rush University Medical Center, Chicago, IL 60612, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, NIH/NCI.
Abstract (Originalsprache)
Objective
Ovarian high-grade serous carcinoma (HGSC) is a fatal malignancy of women. Alterations in the expression of nuclear proteins are early steps in malignant transformation; nucleolin is one such protein. Changes in nucleolin expression and circulatory levels during ovarian HGSC development are unknown. The study goal was to determine if tissue and circulatory levels of nucleolin change in response to malignant transformation leading to ovarian HGSC.
Methods
Sera, ovaries, and BRCA+ fimbria from healthy subjects, and sera and tumor tissues from patients (n = 10 each), and healthy hens and hens with HGSC were examined in exploratory and prospective studies for nucleolin expression by immunohistochemistry, immunoblotting, gene expression, and immunoassay, and analyzed by analysis of variance (ANOVA).
Results
Compared with normal, nucleolin expression was higher in patients and hens with ovarian HGSC and in women with a risk of HGSC (P < 0.05). Compared with normal (1400 + 105 pg/mL, n = 8), serum nucleolin levels were 1.5 and 1.7-fold higher in patients with early- (n = 5) and late-stage (n = 5) HGSC, respectively. Additionally, serum nucleolin levels increased significantly (P < 0.05) prior to the formation of detectable masses.
Conclusion
This pilot study concluded that tissue and serum levels of nucleolin increase in association with malignant changes in ovaries and fimbriae leading to ovarian HGSC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anatomy & Cell Biology, Rush University Medical Center, Chicago, IL 60612, USA.
- Department of Animal Sciences, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
- Department of Internal Medicine, Rush University Medical Center, Chicago, IL 60612, USA.
- Department of Pathology, Rush University Medical Center, Chicago, IL 60612, USA.
- Department of Obstetrics and Gynecology, Rush University Medical Center, Chicago, IL 60612, USA.
ORCID-Profile: Elizabeth A Paris
Förderung
- NCI NIH HHS
- National Institutes of Health
- NIH/NCI
Zitieren
APA
Paris, E. A., Bahr, J. M., Basu, S., & Barua, A. (2023). Changes in Nucleolin Expression during Malignant Transformation Leading to Ovarian High-Grade Serous Carcinoma. Cancers, 15(3), 661. https://doi.org/10.3390/cancers15030661
Vancouver
Paris EA, Bahr JM, Basu S, Barua A. Changes in Nucleolin Expression during Malignant Transformation Leading to Ovarian High-Grade Serous Carcinoma. Cancers. 2023;15(3):661. doi:10.3390/cancers15030661
BibTeX
@article{Paris2023,
author = {Paris, Elizabeth A and Bahr, Janice M and Basu, Sanjib and Barua, Animesh},
title = {Changes in Nucleolin Expression during Malignant Transformation Leading to Ovarian High-Grade Serous Carcinoma},
journal = {Cancers},
year = {2023},
volume = {15},
number = {3},
pages = {661},
doi = {10.3390/cancers15030661}
}
EUVIMED